EXOSYSTEMS, The Republic of Korea - Komachine Supplier Profile and Product List

- EXOSYSTEMS is a digital healthcare company creating a new healthcare lifestyle by converging robotics, AI, ICT, and medicine. Its core business involves providing AI digital biomarker-based solutions for the diagnosis, monitoring, and personalized treatment of neuromuscular and musculoskeletal disorders. Specifically, the company offers 'exoRehab,' a digital rehabilitation solution utilizing wearable sensors and AI analysis technology for personalized rehabilitation exercises and remote monitoring services.EXOSYSTEMS is a digital healthcare company creating a new healthcare lifestyle by converging robotics, AI, ICT, and medicine. Its core business involves providing AI digital biomarker-based solutions for the diagnosis, monitoring, and personalized treatment of neuromuscular and musculoskeletal disorders. Specifically, the company offers 'exoRehab,' a digital rehabilitation solution utilizing wearable sensors and AI analysis technology for personalized rehabilitation exercises and remote monitoring services.
- exoRehab: A digital rehabilitation solution employing wearable sensors and AI analysis technology. It precisely measures and analyzes musculoskeletal movements and muscle usage data, providing personalized rehabilitation exercises and remote monitoring services. The solution has demonstrated effectiveness in improving muscle strength and gait function through neuromuscular electrical stimulation (NMES). Quantitative knee status checks are available anywhere, anytime, thanks to its ability to measure knee range of motion (ROM) and muscle bio-signals (EMG). It supports home-based rehabilitation for patients with difficulty visiting hospitals.exoRehab: A digital rehabilitation solution employing wearable sensors and AI analysis technology. It precisely measures and analyzes musculoskeletal movements and muscle usage data, providing personalized rehabilitation exercises and remote monitoring services. The solution has demonstrated effectiveness in improving muscle strength and gait function through neuromuscular electrical stimulation (NMES). Quantitative knee status checks are available anywhere, anytime, thanks to its ability to measure knee range of motion (ROM) and muscle bio-signals (EMG). It supports home-based rehabilitation for patients with difficulty visiting hospitals.
- exoPill: A digital healthcare device for musculoskeletal function improvement and pain relief. Its multiple attachable modules can be applied to muscle areas on any part of the body to deliver electrical stimulation for functional improvement or pain relief, and measure bio-signals such as muscle condition. Based on the Muscle Function Index (MFI), a core digital biomarker technology that analyzes neuromuscular bio-signals with AI, it provides qualitative indicators like muscle strength, endurance, and receptivity relative to muscle mass.exoPill: A digital healthcare device for musculoskeletal function improvement and pain relief. Its multiple attachable modules can be applied to muscle areas on any part of the body to deliver electrical stimulation for functional improvement or pain relief, and measure bio-signals such as muscle condition. Based on the Muscle Function Index (MFI), a core digital biomarker technology that analyzes neuromuscular bio-signals with AI, it provides qualitative indicators like muscle strength, endurance, and receptivity relative to muscle mass.
- exoFit: An AI-powered platform for exercise performance assessment and monitoring. It offers an all-in-one exercise management solution, from pre-exercise consultation to real-time feedback during workouts and post-exercise analysis. This next-generation product focuses on the rehabilitation of neurotic patients by inheriting key technologies from previous products.exoFit: An AI-powered platform for exercise performance assessment and monitoring. It offers an all-in-one exercise management solution, from pre-exercise consultation to real-time feedback during workouts and post-exercise analysis. This next-generation product focuses on the rehabilitation of neurotic patients by inheriting key technologies from previous products.
- AI Digital Biomarker Technology: A core technology that analyzes neuromuscular bio-signals with AI to support early diagnosis, severity assessment, and progress monitoring of neuromuscular and musculoskeletal disorders. It is applied in solutions for sarcopenia diagnosis assistance, dynamic electromyography for movement analysis, and remote medical monitoring. This technology significantly enhances operational efficiency by shortening labor-intensive measurement processes to approximately 3 minutes.AI Digital Biomarker Technology: A core technology that analyzes neuromuscular bio-signals with AI to support early diagnosis, severity assessment, and progress monitoring of neuromuscular and musculoskeletal disorders. It is applied in solutions for sarcopenia diagnosis assistance, dynamic electromyography for movement analysis, and remote medical monitoring. This technology significantly enhances operational efficiency by shortening labor-intensive measurement processes to approximately 3 minutes.
- AI-Powered Personalized Digital Rehabilitation Solution: Combining wearable sensors with AI analysis technology, the company precisely analyzes individual musculoskeletal movements and muscle usage data, offering customized exercise programs and remote monitoring. This differentiates it from conventional one-way rehabilitation protocols.AI-Powered Personalized Digital Rehabilitation Solution: Combining wearable sensors with AI analysis technology, the company precisely analyzes individual musculoskeletal movements and muscle usage data, offering customized exercise programs and remote monitoring. This differentiates it from conventional one-way rehabilitation protocols.
- Medical Device Certification and Clinical Efficacy: 'exoRehab' has obtained medical device approval from the Ministry of Food and Drug Safety and CE certification, making it an officially recognized medical device. Clinical research on digital therapeutic technology for musculoskeletal disorders is being conducted with major Korean hospitals, including Seoul National University Bundang Hospital, Kyung Hee Medical Center, and Pusan National University Hospital, validating its efficacy.Medical Device Certification and Clinical Efficacy: 'exoRehab' has obtained medical device approval from the Ministry of Food and Drug Safety and CE certification, making it an officially recognized medical device. Clinical research on digital therapeutic technology for musculoskeletal disorders is being conducted with major Korean hospitals, including Seoul National University Bundang Hospital, Kyung Hee Medical Center, and Pusan National University Hospital, validating its efficacy.
- Innovative Digital Biomarker Technology: The company developed the Muscle Function Index (MFI) technology, which quantitatively assesses neuromuscular function by analyzing bio-signals with AI, a world-first. This technology enables 'EXOMed-DeepSarc,' a sarcopenia diagnosis system, to shorten complex diagnostic processes to about 3 minutes and is applicable even to patients with mobility impairments, demonstrating significant innovation.Innovative Digital Biomarker Technology: The company developed the Muscle Function Index (MFI) technology, which quantitatively assesses neuromuscular function by analyzing bio-signals with AI, a world-first. This technology enables 'EXOMed-DeepSarc,' a sarcopenia diagnosis system, to shorten complex diagnostic processes to about 3 minutes and is applicable even to patients with mobility impairments, demonstrating significant innovation.
- Global Market Competitiveness and Awards: Recipient of CES 2026 Innovation Awards in the AI and Digital Health categories for exoRehab. Awarded the Minister of Science and ICT Award at the 2023 Korea Invention Patent Exhibition for its 'Sarcopenia Diagnosis System' patent. Actively preparing for entry into European and North American markets.Global Market Competitiveness and Awards: Recipient of CES 2026 Innovation Awards in the AI and Digital Health categories for exoRehab. Awarded the Minister of Science and ICT Award at the 2023 Korea Invention Patent Exhibition for its 'Sarcopenia Diagnosis System' patent. Actively preparing for entry into European and North American markets.
- Integrated Hardware and Software Technology: Possession of both wearable hardware development capabilities and AI-based software analysis technology provides a strong advantage in actual product development and commercialization. The company ensures 'data sovereignty' by collecting and analyzing data from its proprietary devices.Integrated Hardware and Software Technology: Possession of both wearable hardware development capabilities and AI-based software analysis technology provides a strong advantage in actual product development and commercialization. The company ensures 'data sovereignty' by collecting and analyzing data from its proprietary devices.
- Rehabilitation Medicine: Rehabilitation training and monitoring for patients with neuromuscular and musculoskeletal disorders.Rehabilitation Medicine: Rehabilitation training and monitoring for patients with neuromuscular and musculoskeletal disorders.
- Digital Healthcare: Provision of home-based remote rehabilitation and health management solutions.Digital Healthcare: Provision of home-based remote rehabilitation and health management solutions.
- Geriatric Medicine and Sarcopenia Management: Assistance in sarcopenia diagnosis and preventive management for the elderly population.Geriatric Medicine and Sarcopenia Management: Assistance in sarcopenia diagnosis and preventive management for the elderly population.
- Fitness and Wellness: Personalized musculoskeletal health management and exercise performance assessment.Fitness and Wellness: Personalized musculoskeletal health management and exercise performance assessment.
- South Korea, VietnamSouth Korea, Vietnam
- Germany (MEDICA exhibition participation), Preparing for European market entryGermany (MEDICA exhibition participation), Preparing for European market entry
- USA (CES exhibition participation), Preparing for North American market entryUSA (CES exhibition participation), Preparing for North American market entry
- Medical Device Approval from the Ministry of Food and Drug SafetyMedical Device Approval from the Ministry of Food and Drug Safety
- CE Medical Certification (European Medical Device Certification)CE Medical Certification (European Medical Device Certification)
- K-GMP (Korea Good Manufacturing Practice) ApprovalK-GMP (Korea Good Manufacturing Practice) Approval
- CES 2026 Innovation Award in AI Category (exoRehab)CES 2026 Innovation Award in AI Category (exoRehab)
- CES 2026 Innovation Award in Digital Health CategoryCES 2026 Innovation Award in Digital Health Category
- CES 2024 Innovation Award in Digital Health Category (AI Digital Biomarker-based Healthcare Solution)CES 2024 Innovation Award in Digital Health Category (AI Digital Biomarker-based Healthcare Solution)
- Minister of Science and ICT Award at the 2023 Korea Invention Patent Exhibition ('Sarcopenia Diagnosis System' patent)Minister of Science and ICT Award at the 2023 Korea Invention Patent Exhibition ('Sarcopenia Diagnosis System' patent)
- World's first development of AI Digital Biomarker MFI (Muscle Function Index) technologyWorld's first development of AI Digital Biomarker MFI (Muscle Function Index) technology
- Research on AI Digital Biomarker analysis for neuromuscular function assessment published in the top-tier international journal IEEE-TNSRE (Transactions on Neural Systems And Rehabilitation Engineering)Research on AI Digital Biomarker analysis for neuromuscular function assessment published in the top-tier international journal IEEE-TNSRE (Transactions on Neural Systems And Rehabilitation Engineering)
- Research on the neuromuscular rehabilitation effects of personalized digital intervention solutions published in the world-renowned SCI-indexed geriatric medicine international journal JAMDA (The Journal of Post-Acute and Long-Term Care Medicine)Research on the neuromuscular rehabilitation effects of personalized digital intervention solutions published in the world-renowned SCI-indexed geriatric medicine international journal JAMDA (The Journal of Post-Acute and Long-Term Care Medicine)
- Designation as an Innovative Medical Device (AI Digital Biomarker-based Sarcopenia Diagnosis SW 'EXOMed-DeepSarc')Designation as an Innovative Medical Device (AI Digital Biomarker-based Sarcopenia Diagnosis SW 'EXOMed-DeepSarc')